Once these PC patients had survived the cancer at least that long and were in remission, other causes of death had become more common and patients treated with ACE inhibitors likely experienced greater risk of death from non-PC causes due to their diabetes, hypertension, or other indications. This evidence concerns the gene ACE and diabetes mellitus.